Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$790.16M-13,690%-$5.73M-297%$2.91M+150%-$5.86M+60.1%-$14.68M+38.3%
$6.87M+13.2%$6.07M+0.2%$6.06M+0.1%$6.06M+0.1%$6.05M-0.1%
$36.2M+90.3%$19.03M+5.0%$18.13M-1.8%$18.47M+16.9%$15.8M+19.3%
-$228.76M-3,871%$6.07M-84.7%$39.68M+230%$12.04M+714%-$1.96M
$664K+10.7%$600K+221%$187K+48.4%$126K+207%$41K+105%
-$11.57M$0+100%-$2.23M+66.3%-$6.6M+59.1%-$16.13M
$270.08M+2,901%$9M-44.1%$16.1M+85.3%$8.69M+36.6%$6.36M+19.1%
$28.48M+81.8%$15.66M-70.9%$53.9M+230%$16.36M+253%-$10.68M-2,192%
-$229.43M-4,297%$5.47M-86.2%$39.49M+231%$11.91M+695%-$2M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Mirum Pharmaceuticals, Inc. generate?
Mirum Pharmaceuticals, Inc. (MIRM) generated -$171.0M in operating cash flow over the trailing twelve months.
What is Mirum Pharmaceuticals, Inc.'s free cash flow?
After $1.6M of capital expenditures, Mirum Pharmaceuticals, Inc.'s free cash flow was -$172.6M over the trailing twelve months, down 45270.7% year over year.
Where does Mirum Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.